Medical and Pharmaceutical Puma Biotechnology shares get favourable price bump on strong Q2 results The absence of negative developments over the past month has helped sentiment recover Joseph MortonAugust 11, 2025
Medical and Pharmaceutical Citi boosts share target for ArriVent BioPharma by US$4 on positive trial data The biotech operator's lung cancer drug enabled 16-month progression-free survival among patients Rowan DunneJune 23, 2025